Progyny (PGNY)
(Delayed Data from NSDQ)
$32.54 USD
+0.50 (1.56%)
Updated Apr 29, 2024 03:59 PM ET
After-Market: $32.54 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for Progyny, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,089 | 787 | 501 | 345 | 230 |
Cost Of Goods | 850 | 620 | 388 | 275 | 184 |
Gross Profit | 239 | 167 | 112 | 70 | 46 |
Selling & Adminstrative & Depr. & Amort Expenses | 177 | 144 | 80 | 62 | 36 |
Income After Depreciation & Amortization | 62 | 23 | 32 | 8 | 10 |
Non-Operating Income | 9 | 1 | 0 | 0 | -18 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 71 | 24 | 32 | 9 | -9 |
Income Taxes | 9 | -6 | -33 | -38 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 62 | 30 | 66 | 46 | -9 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 62 | 30 | 66 | 46 | -9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 64 | 25 | 34 | 10 | 12 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 2 | 2 |
Income After Depreciation & Amortization | 62 | 23 | 32 | 8 | 10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 100.67 | 99.96 | 100.36 | 99.06 | 20.74 |
Diluted EPS Before Non-Recurring Items | 0.62 | 0.30 | 0.66 | 0.18 | 0.11 |
Diluted Net EPS (GAAP) | 0.62 | 0.30 | 0.66 | 0.47 | -0.41 |
Fiscal Year end for Progyny, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 269.94 | 280.89 | 279.37 | 258.39 |
Cost Of Goods | NA | 213.05 | 218.27 | 218.73 | 199.75 |
Gross Profit | NA | 56.89 | 62.62 | 60.64 | 58.64 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 43.09 | 44.44 | 45.46 | 43.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.80 | 18.18 | 15.18 | 15.01 |
Non-Operating Income | NA | 2.46 | 2.74 | 1.98 | 1.32 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 16.26 | 20.93 | 17.17 | 16.33 |
Income Taxes | NA | 2.79 | 5.03 | 2.18 | -1.35 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 13.47 | 15.90 | 14.99 | 17.68 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 13.47 | 15.90 | 14.99 | 17.68 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 100.75 | 100.88 | 100.62 | 100.17 |
Diluted EPS Before Non-Recurring Items | NA | 0.13 | 0.16 | 0.15 | 0.18 |
Diluted Net EPS (GAAP) | NA | 0.13 | 0.16 | 0.15 | 0.18 |